Kanaph Therapeutics Inc
KOSDAQ:0082N0
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
K
|
Kanaph Therapeutics Inc
KOSDAQ:0082N0
|
KR |
|
T
|
Toyobo Co Ltd
F:TO7
|
JP |
|
Blue Moon Metals Inc
F:8SX0
|
CA |
|
Telekom Malaysia Bhd
KLSE:TM
|
MY |
|
Arkha Jayanti Persada Tbk PT
IDX:ARKA
|
ID |
|
S
|
Seohee Construction Co Ltd
KOSDAQ:035890
|
KR |
|
Al Maather REIT Fund
SAU:4334
|
SA |
|
B
|
Birchcliff Energy Ltd
SWB:39B
|
CA |
|
Fatfish Group Ltd
F:1JU
|
AU |
|
C
|
Classic Scenic Bhd
KLSE:HEXRTL
|
MY |
|
3
|
3R Games SA
WSE:3RG
|
PL |
|
Lion One Metals Ltd
XTSX:LIO
|
CA |
|
M
|
MK Electron
KOSDAQ:033160
|
KR |
|
China Everbright Water Ltd
F:BIU2
|
CN |
|
M
|
Motor Oil Hellas Corinth Refineries SA
ATHEX:MOH
|
GR |
|
Modernland Realty Tbk PT
IDX:MDLN
|
ID |
|
J
|
Jeronimo Martins SGPS SA
ELI:JMT
|
PT |
|
J
|
Japan Airlines Co Ltd
SWB:JAL
|
JP |
|
4imprint Group PLC
LSE:FOUR
|
UK |
|
Compania Espanola de Viviendas en Alquiler SA
MAD:CEV
|
ES |
|
A
|
Astra Graphia Tbk PT
XMUN:IUA
|
ID |
|
Sona BLW Precision Forgings Ltd
BSE:543300
|
IN |
|
Kri-Kri Milk Industry SA
F:AO2
|
GR |
|
E
|
Eurasia Mining PLC
F:EUH
|
UK |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de Kanaph Therapeutics Inc.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace Kanaph Therapeutics
Kanaph Therapeutics Inc. engages in the research and development of antibody drugs based on human genome based drug development technology. The company is headquartered in Seoul, Seoul. The company went IPO on 2026-03-16. The firm is engaged in the research and development of anticancer drugs and ophthalmic disease treatments based on human genome-based drug discovery technologies. The firm primarily researches and develops bispecific antibodies including immuno-oncology and ophthalmic disease treatments, targeted anticancer antibody-drug conjugate (ADC) new drugs and ADC platform…
- Sede central
- Corea KR
- Fecha de salida a bolsa
- 16 mar., 2026
